Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDUSTRY × FluMist × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Influenza, Human 1

Interventions

Paclitaxel 405 Carboplatin 359 Gemcitabine 329 Docetaxel 328 Cisplatin 297 Bevacizumab 284 pembrolizumab 275 Nivolumab 212 Pemetrexed 201 Capecitabine 195 Dexamethasone 173 Rituximab 169 Fluorouracil 166 Trastuzumab 159 Cyclophosphamide 159 Oxaliplatin 134 Prednisone 125 atezolizumab 124 Erlotinib Hydrochloride 123 Ipilimumab 122 Cetuximab 121 Irinotecan 114 Doxorubicin 112 Leucovorin 108 Bortezomib 102 Sorafenib 97 Lenalidomide 95 Sunitinib 93 Radiotherapy 79 Everolimus 79

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00112112 2017-08-14

Safety Study to Evaluate FluMist in Immunocompromised Children

MedImmune LLC

Phase 1 Completed

20 enrolled 70 charts

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡